| |
| |
|
| Insider
Information: |
Higgins John L |
| Relationship: |
Director |
| City: |
Palo Alto |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
2,806,928 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$49,374,432 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
2,806,928 |
|
|
| Total
Value |
$49,374,432 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
11
|
|
Stock
price went up :
|
0
|
5
|
| Stock
price went down : |
0
|
6
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -34.7%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Ligand Pharmaceuticals Inc |
LGND |
Director |
2022-12-28 |
417,695 |
2007-02-01 |
0 |
Premium* |
|
|
Techne Corp |
TECH |
Director |
2024-05-14 |
36,608 |
2013-10-31 |
0 |
Premium* |
|
|
OmniAb, Inc |
OABI |
Director |
2024-01-30 |
2,352,625 |
2022-11-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
165 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 6 of 7
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2021-11-12 |
4 |
S |
$160.50 |
$481,500 |
D/D |
(3,000) |
335,095 |
0 |
% |
|
| LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2022-01-26 |
4 |
A |
$0.00 |
$0 |
D/D |
23,166 |
358,261 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2022-01-26 |
4 |
D |
$113.68 |
$1,050,744 |
D/D |
(9,243) |
349,018 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2022-02-15 |
4 |
D |
$123.68 |
$732,557 |
D/D |
(5,923) |
340,593 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2022-05-09 |
4 |
OE |
$21.92 |
$175,360 |
D/D |
8,000 |
348,593 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2022-06-30 |
4 |
A |
$75.84 |
$12,437 |
D/D |
164 |
369,180 |
0 |
- |
|
| TECH |
Techne Corp |
Director |
• • – |
2022-08-10 |
4 |
OE |
$66.90 |
$227,460 |
D/D |
3,400 |
8,006 |
0 |
- |
|
| TECH |
Techne Corp |
Director |
• • – |
2022-08-10 |
4 |
S |
$373.99 |
$751,194 |
D/D |
(1,992) |
6,014 |
0 |
% |
|
| TECH |
Techne Corp |
Director |
• • – |
2022-08-11 |
4 |
S |
$380.71 |
$197,322 |
D/D |
(512) |
5,502 |
0 |
% |
|
| LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2022-09-15 |
4 |
S |
$90.00 |
$180,000 |
D/D |
(2,000) |
367,180 |
0 |
% |
|
| LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2022-09-16 |
4 |
S |
$89.35 |
$268,050 |
D/D |
(3,000) |
364,180 |
0 |
% |
|
| TECH |
Techne Corp |
|
– • – |
2022-10-27 |
4 |
A |
$0.00 |
$0 |
D/D |
338 |
5,840 |
0 |
- |
|
| OABI |
OmniAb, Inc |
Director |
– • – |
2022-11-01 |
4 |
A |
$0.00 |
$0 |
D/D |
2,176,521 |
2,176,521 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2022-11-01 |
4 |
A |
$0.00 |
$0 |
D/D |
45,922 |
424,731 |
0 |
- |
|
| OABI |
OmniAb, Inc |
Director |
– • – |
2022-11-02 |
4 |
OE |
$2.52 |
$621,553 |
D/D |
246,648 |
2,423,169 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2022-11-17 |
4 |
AS |
$78.32 |
$783,173 |
D/D |
(10,000) |
416,731 |
0 |
% |
|
| LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2022-11-18 |
4 |
OE |
$12.78 |
$127,800 |
D/D |
10,000 |
426,731 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2022-11-30 |
4 |
D |
$72.90 |
$714,639 |
D/D |
(9,803) |
416,928 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2022-12-12 |
4 |
OE |
$12.78 |
$255,600 |
D/D |
20,000 |
436,928 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2022-12-12 |
4 |
D |
$64.80 |
$255,571 |
D/D |
(3,944) |
432,984 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2022-12-16 |
4 |
AS |
$61.87 |
$618,657 |
D/D |
(10,000) |
422,984 |
0 |
% |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2022-12-28 |
4 |
D |
$66.29 |
$350,608 |
D/D |
(5,289) |
417,695 |
0 |
- |
|
| OABI |
OmniAb, Inc |
Director |
– • – |
2022-12-28 |
4 |
A |
$3.66 |
$94,845 |
D/D |
25,914 |
2,397,255 |
0 |
- |
|
| OABI |
OmniAb, Inc |
Director |
– • – |
2023-01-04 |
4 |
A |
$3.23 |
$186,704 |
D/D |
57,803 |
2,339,452 |
0 |
- |
|
| OABI |
OmniAb, Inc |
Director |
– • – |
2023-01-30 |
4 |
A |
$0.00 |
$0 |
D/D |
39,517 |
2,462,686 |
0 |
- |
|
165 Records found
|
|
Page 6 of 7 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
